Yes, odd share price behaviour. Tho that's been a common theme with Neuren from since I first invested 7 years ago. Notable that ACAD share price pretty steady.Neuren is still valued at $20+ post approval by any reasonable calculation in my view.
Theoretically share price before approval has no bearing on valuation of Neuren post approval. Perhaps best just to close our eyes and come back 12 Mar
Share Price, page-3832
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.71 |
Change
-0.590(3.41%) |
Mkt cap ! $2.135B | |||
| Open | High | Low | Value | Volume |
| $17.50 | $17.55 | $16.57 | $10.01M | 594.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 598 | $16.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.87 | 1676 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |